Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects

NCT01713803 is registered in ClinicalTrials.gov with BioDelivery Sciences International as lead sponsor.

NCT NCT01713803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01713803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects
Lead sponsor
BioDelivery Sciences International
Phase
Phase 3
Overall status
Withdrawn
Start date
Not reported
Completion date
May 1, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence